Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031

icon1
USD 0.70 BN
MARKET SIZE, 2031
icon2
CAGR 8.6%
(2026-2031)
icon3
200
REPORT PAGES
icon4
180
MARKET TABLES

OVERVIEW

europe-companion-animal-diagnostics-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The Europe companion animal diagnostics market, valued at US$0.43 billion in 2025, stood at US$0.46 billion in 2026 and is projected to advance at a resilient CAGR of 8.6% from 2026 to 2031, culminating in a forecasted valuation of US$0.70 billion by the end of the period. The market for diagnostics of companion animals in Europe is experiencing fast growth owing to factors such as increased pet ownership, animal health awareness, and advanced veterinary care being more widely accepted and costly. The presence of chronic and infectious diseases in pets is, therefore, a major factor that drives the need for accurate and early diagnostic testing, while technological improvements, like rapid point-of-care tests and molecular diagnostics, are positively impacting the overall detection process with regard to speed and reliability. In this respect, the abovementioned conditions are together pushing the veterinary diagnostic solutions market through clinics and laboratories in Europe.

KEY TAKEAWAYS

  • By Country
    The companion animal diagnostics market in Germany accounted for 18.9% revenue share in 2025.
  • By Product
    The consumables segment accounted for the largest share of the Europe companion animal diagnostics market in 2025.
  • By Animal Type
    Dogs held the largest market share of 64.0% of the Europe companion animal diagnostics market in 2025.
  • By Technology
    The clinical biochemistry segment accounted for the largest market share in 2025.
  • By Application
    The clinical pathology segment is projected to be the fastest-growing segment with a CAGR of 10.4% during the forecast period.
  • By End User
    The diagnostic laboratories segment accounted for the largest market share in 2025.
  • Competitive Landscape: Key Players
    Idexx and Zoetis Service LLC were identified as some of the star players in Europe, given their strong market share and product footprint.
  • Competitive Landscape: SMEs
    Biopanda Reagents Ltd. and EurolyserDiagnostica GmbH, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The growth of the companion animal diagnostics market in Europe is expanding with the rise in the number of pet owners, the health of animals becoming a more critical aspect, and the rise in spending on modern veterinary services. At the same time, the increased occurrence of chronic and infectious pet diseases is making the demand for accurate and quick diagnostic tools more pronounced. Innovative methods such as rapid point-of-care testing and molecular tests, on the other hand, are making the diagnostic process more accurate and faster. All these factors are facilitating the increased adoption of diagnostic technologies in the veterinary practices and labs in the region.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Pet humanization and the advancement of technology are the major causes for the change in the Europe companion animal diagnostics market. The main trend is that owner spending has increased significantly, as owners consider their pets as family members, which in turn drives the demand for preventive and early-stage diagnostics. The market for these diagnostics has been immensely disrupted, along with the rapidly increasing acceptance of Point-of-Care (POC) diagnostics that allow veterinarians to perform advanced tests such as immunodiagnostics, clinical biochemistry, and molecular assays in a matter of minutes at the clinic. Besides, the use of AI in the analysis of imaging and urine sediment is among the top technological trends in enhancing diagnostic speed and accuracy. Despite this progress, the situation is worsened by the high prices of the state-of-the-art instruments and the lack of skilled veterinary practitioners who could work with and interpret the results of these technologies.

europe-companion-animal-diagnostics-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing companion animal population
  • Rising demand for pet insurance and growing animal health expenditure
RESTRAINTS
Impact
Level
  • Rising pet care costs
OPPORTUNITIES
Impact
Level
  • Use of advanced technologies to improve disease diagnosis accuracy in companion animals
  • Growing demand for rapid tests and portable instruments for point-of-care diagnostic services
CHALLENGES
Impact
Level
  • Shortage of veterinary practitioners

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

DRIVERS: Increasing companion animal population

The growth of the Europe companion animal diagnostics market is fundamentally anchored in the trend of "pet humanization", where companion animals are increasingly viewed as family members. This shift is deeply rooted in the well-documented positive health benefits of pet ownership for humans, including reduced stress and improved psychological well-being, which has fueled a surge in adoption rates across the continent. Data confirms this, with the canine population in Europe expanding from USD 104.34 million in 2022 to USD 106.36 million in 2023 ( Source: European Pet Food Industry Federation, FEDIAF), and a total European pet population nearing USD 352 million. This continually expanding and aging pet population directly drives a proportionate rise in demand for premium pet care products and advanced veterinary services, acting as the primary engine of growth for dependent industries such as the companion animal diagnostics market, particularly for tools used in early and preventative care.

RESTRAINTS: Rising pet care costs

The increase in diagnostic market sales of companion animals in Europe is extremely limited due to the rising costs of pet care, which makes a financial burden on the pet owners and, at the same time, limits the demand for modern diagnostic services. The veterinary labs, consultations, and treatments with preventive care have all experienced price surges owing to the rising costs of labor, medical supplies, and the use of advanced diagnostic technologies. Thus, a considerable proportion of pet owners, more so the ones with no comprehensive pet insurance, are inclined to defer or even refuse diagnostic testing, preferring to go for basic care or symptomatic treatment instead. The sensitivity to cost is most apparent in Southern and Eastern Europe, which consumes less household resources, thus leading to an uneven adoption of advanced diagnostics across the region. Therefore, while diagnostic technology and methods keep progressing, the high expenses that are not covered by the insurance still remain a big hurdle, which slows down the growth of the market, and the veterinarians do not have the possibility to explore the full potential of the new diagnostic platforms.

OPPORTUNITIES: Use of advanced technologies to improve disease diagnosis accuracy in companion animals

The veterinary healthcare sector is just at the beginning of the adoption of advanced technologies such as AI and ML, but the first applications already indicate that these technologies can be very useful for diagnosing companion animals accurately. With the help of these tools, the imaging datasets, and electronic medical records are getting integrated to spot disease patterns already and more reliably than the traditional ways. One example is the Aptech Diagnostics by Mars Petcare scientists who introduced RenalTech, an AI-powered predictive tool that has the ability to detect chronic kidney disease (CKD) in cats up to two years earlier than the clinical diagnosis, which is a substantial progress considering that CKD affects almost one-third of the cat population and is the number one cause of death in cats older than five years. These advancements are clear indicators that AI and ML are going to be very useful in veterinary diagnostics as they will make it possible to detect the disease earlier, lessen the uncertainty surrounding the diagnosis and thus promote health management to be more proactive.

CHALLENGES: Shortage of veterinary practitioners

The companion animal healthcare ecosystem is increasingly strained by a persistent shortage of veterinary practitioners. As pet ownership grows and the demand for timely diagnostic testing rises, many clinics and diagnostic facilities face capacity limitations due to insufficient staffing. This shortage leads to longer wait times, delayed diagnostic workups, and reduced access to specialized testing, ultimately affecting the accuracy and speed of clinical decision-making. The limited availability of trained veterinarians also places additional pressure on existing staff, hindering their ability to adopt new diagnostic technologies or expand service offerings. As a result, the shortage of veterinary professionals acts as a significant challenge to market growth, affecting both diagnostic throughput and the adoption of advanced companion animal diagnostic solutions.

EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
In-clinic diagnostic analyzers, rapid test kits, imaging systems, and reference laboratory services for companion animals Fast and accurate diagnostics, improved clinical decision-making, streamlined veterinary workflows
Point-of-care diagnostic tests and reference lab services integrated with animal health solutions Early disease detection, integrated diagnostics–therapeutics approach, improved treatment outcomes
Diagnostic imaging systems, hematology and biochemistry analyzers for veterinary use High-quality imaging, reliable lab results, enhanced diagnostic confidence
Microbiology and infectious disease diagnostics for veterinary applications Accurate pathogen detection, improved infection control, strong European lab presence
Diagnostic support tools and disease-specific testing solutions for companion animals Targeted diagnostics, strong alignment with therapeutic portfolios, trusted European brand

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The landscape of the Europe companion animal diagnostics market is primarily dictated by the manufacturers who are creating advanced testing kits along with imaging systems and digital diagnostic tools, and also by the veterinary surgeons and hospitals, and other end users that comprise diagnostic laboratories, research institutes, universities, and a rapidly growing segment of pet owners practicing home-care who depend upon fast and dependable diagnostics to make the right decisions regarding treatment and thus improve animal health outcomes. The regulatory bodies, such as the European Medicines Agency (EMA), national veterinary authorities, and the EU regulatory framework that supervises diagnostic device safety, quality, and data integrity, are the ones controlling this environment. Their policies will affect product approvals, laboratory standards, and the usage of digital tools, whereas the latter will impact innovations and the adoption of the market in Europe.

europe-companion-animal-diagnostics-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

europe-companion-animal-diagnostics-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Europe Companion Animal Diagnostics Market, By Product

The Europe companion animal diagnostics market is divided into consumables and instruments based on product. The consumables segment dominates the market, as the demand for routine diagnostocs testing is increasing in tandem with the growth of chronic and infectious diseases, including diabetes and parasitic infections, in pets.

Europe Companion Animal Diagnostics Market, By Animal Type

By animal type, the companion animal diagnostics market in Europe is dominated by dogs. They are susceptible to a number of diseases, such as heart problems, tumors, diabetes, and infections; they need frequent diagnostic tests to be managed properly.

Europe Companion Animal Diagnostics Market, By Application

The clinical pathology segment is projected to experience significant growth due to the high frequency of pathology testing performed on pets. The use of clinical pathology in vet practice has increased over the years due to its reliability in diagnosing and monitoring diseased conditions, particularly chronic ones, thereby making it the most widely used diagnostic method.

Europe Companion Animal Diagnostics Market, By End User

The diagnostic laboratories segment held the largest market share in 2025. This dominance is driven by the high volume of samples sent from both small and large veterinary practices for advanced analysis. Growing awareness among pet owners about routine and preventive diagnostic testing continues to boost sample inflow to these labs. As preventive care becomes more widely adopted across Europe, the demand for comprehensive laboratory-based diagnostics is expected to further accelerate during the forecast period.

REGION

UK to be fastest-growing country in Europe companion animal diagnostics market during forecast period

The UK is projected to record the highest CAGR over the forecast period. This is driven by factors such as the increasing adoption of automated therapeutic apheresis procedures, recent supportive initiatives within the NHS, and the renewed focus on boosting domestic plasma collection for essential plasma-derived therapies.

europe-companion-animal-diagnostics-market Region

EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX

In the Europe companion animal diagnostics market matrix, Zoetis (Star) dominates with its massive scale, deep integration, and advanced diagnostic ecosystem, notably including the AI-powered Vetscan Imagyst platform for rapid, in-clinic testing. Conversely, Virbac (Emerging Leader) is gaining momentum, leveraging its strong European presence and focus on specialized, integrated health solutions, positioning itself to capture a larger share from veterinary practices seeking a broader, holistic product line.

europe-companion-animal-diagnostics-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

  • IDEXX (US)
  • Zoetis Services LLC (US)
  • Mars, Incorporated (US)
  • FUJIFILM Corporation (Japan)
  • bioMérieux (France)
  • Thermo Fisher Scientific Inc (US)
  • Virbac (France)
  • Neogen Corporation (US)
  • INDICAL BIOSCIENCE GmbH (Germany)
  • IDvet (France)
  • Randox Laboratories Ltd. (UK)
  • Shenzhen Mindray Animal Medical Technology Co., LTD. (China)
  • Bionote USA Inc. (US)
  • Boule (Sweden)
  • EUROIMMUN Medizinische Labordiagnostika AG (Germany)
  • Biopanda Reagents Ltd (UK)
  • Nova Biomedical (US)
  • Megacor Veterinary Diagnostics (Austria)
  • Eurolyser Diagnostica GmbH (Austria)
  • URIT MEDICAL ELECTRONIC CO., LTD. (China)
  • Fassisi GmbH (Germany)
  • Swissavans AG (Switzerland)
  • Ring Biotechnology Co Ltd (China)
  • Alvedia (France)

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 0.43 Billion
Market Forecast in 2031 (Value) USD 0.70 Billion
Growth Rate CAGR of 8.6% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Million/Billion), Volume (Thousand Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Product:
    • Consumables
    • Instruments
  • By Application:
    • Clinical Pathology
    • Bacteriology
    • Virology
    • Parasitology
    • Others
  • By Animal Type:
    • Dogs
    • Cats
    • Horses
    • Others
  • By End User:
    • Diagnostic Laboratories
    • Veterinary Hospitals & Clinics
    • Research Institutes & Universities
    • Home Care Settings I By Technology
Countries Covered Germany, Italy, France, Spain, UK, Benelux, Netherlands, Belgium, Denmark, Rest of Europe

WHAT IS IN IT FOR YOU: EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET REPORT CONTENT GUIDE

europe-companion-animal-diagnostics-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis In-depth assessment of companion animal diagnostic solutions by product type (diagnostics), animal type, and end use (veterinary clinics, diagnostic labs, home care testing) Evaluation of emerging diagnostic technologies such as point-of-care testing (POCT), AI-enabled diagnostic imaging, multiplex assays, portable analyzers, and rapid PCR innovations driving efficiency and accuracy in European veterinary practices
Company Information Comprehensive profiles of key European and global players such as IDEXX Laboratories, Zoetis, Heska, Virbac, Eurolyser, Randox, Thermo Fisher Scientific, and others active in the region Identification of strategic partnerships with veterinary networks, R&D collaborations, M&A activities, product launches, and distributor expansions accelerating market penetration in Europe
Geographic Analysis Country-level demand mapping across major European markets, including Germany, the UK, France, Italy, Spain, Benelux; assessment of regulatory frameworks (EU Veterinary Regulations), adoption patterns, and testing infrastructure maturity Regional market outlook detailing growth opportunities in preventive care diagnostics, increasing pet insurance adoption, rising veterinary healthcare expenditure, and digital diagnostic integration across major European countries

RECENT DEVELOPMENTS

  • July 2024 : Mars, Incorporated acquired Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE. Cerba Vet and ANTAGENE now complement the diagnostics portfolio in Mars Petcare’s Science & Diagnostics division.
  • June 2024 : IDEXX launched the Catalyst Pancreatic Lipase Test (Chemistry Analyzer). The Catalyst Pancreatic Lipase test is a single-slide solution for canine and feline patients that helps identify pancreatitis.
  • May 2024 : Zoetis Services LLC launched the Vetscan OptiCell (Analyzer), which is a cartridge-based AI-powered hematology analyzer that provides advanced Complete Blood Count (CBC) analysis.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
4
MARKET OVERVIEW
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
4.2.4
CHALLENGES
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
5
INDUSTRY TRENDS
Maps the market evolution with focus on trend catalysts, risk factors, and growth opportunities across segments.
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
5.2
MACROECONOMICS INDICATORS
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
5.2.3
TRENDS IN EUROPE HEALTHCARE INDUSTRY
 
 
 
 
5.2.4
TRENDS IN EUROPE MEDICAL DEVICE INDUSTRY
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END-USE INDUSTRY, 2023-2025
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023-2025
 
 
 
 
5.6.3
AVERAGE SELLING PRICE TREND, BY APPLICATION, 2023-2025
 
 
 
 
5.6.4
AVERAGE SELLING PRICE TREND, BY COUNTRY, 2023-2025
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE 9018)
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE 9018)
 
 
 
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.10
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.11
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
5.12
IMPACT OF 2025 US TARIFF – EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
5.12.2
KEY TARIFF RATES
 
 
 
 
5.12.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.12.4
IMPACT ON COUNTRIES
 
 
 
 
 
5.12.4.1
GERMANY
 
 
 
 
5.12.4.2
UK
 
 
 
 
5.12.4.3
FRANCE
 
 
 
5.12.5
IMPACT ON END-USE INDUSTRIES
 
 
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
6.1.1
PORTABLE INSTRUMENTS
 
 
 
 
6.1.2
MOLECULAR DIAGNOSTICS
 
 
 
 
6.1.2
AUTOMATED COLLECTION SYSTEMS
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
6.2.1
WEARABLE HEALTH MONITORING DEVICES
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
6.3.1
RAPID VET DIAGNOSTIC KITS
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET
 
 
 
 
 
 
6.7.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
6.7.2
BEST PRACTICES IN EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET
 
 
 
 
6.7.3
CASE STUDIES OF AI IMPLEMENTATION IN THE EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET
 
 
 
 
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
6.7.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
7.2.1
RECYCLED AND ECO-FRIENDLY MATERIALS FOR COMPANION ANIMAL DIAGNOSTICS PRODUCTS
 
 
 
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
9
EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY EUROPE COMPANION ANIMAL DIAGNOSTIC TYPES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS SUPPLIER COMPANIES
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
9.2
CONSUMABLES
 
 
 
 
9.3
INSTRUMENTS
 
 
 
10
EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATON (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY EUROPE COMPANION ANIMAL DIAGNOSTICS PROCEDURES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS SUPPLIER COMPANIES
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
10.2
CLINICAL PATHOLOGY
 
 
 
 
10.3
BACTERIOLOGY
 
 
 
 
10.4
VIROLOGY
 
 
 
 
10.5
PARASITOLOGY
 
 
 
 
10.6
OTHER APPLICATIONS
 
 
 
 
NOTE: OTHER APPLICATIONS IN THE COMPANION ANIMAL DIAGNOSTICS MARKET INCLUDE PREGNANCY TESTING, GENETIC TESTING, AND TOXICOLOGY TESTING.
 
 
 
 
11
EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY EUROPE COMPANION ANIMAL DIAGNOSTICS ANIMAL TYPE, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS SUPPLIER COMPANIES
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
11.2
DOGS
 
 
 
 
11.3
CATS
 
 
 
 
11.4
HORSES
 
 
 
 
11.5
OTHER COMPANION ANIMALS
 
 
 
 
NOTE: THE OTHER COMPANION ANIMALS SEGMENT INCLUDES RABBITS, REPTILES, FISH, BIRDS, AND SMALL MAMMALS.
 
 
 
 
12
EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY EUROPE COMPANION ANIMAL DIAGNOSTICS TECHNOLOGIES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS SUPPLIER COMPANIES
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
12.2
CLINICAL BIOCHEMISTRY
 
 
 
 
 
12.2.1
CLINICAL CHEMISTRY ANALYSIS
 
 
 
 
 
12.2.1.1
REAGENTS, CLIPS, AND CARTRIDGES
 
 
 
 
12.2.1.2
ANALYZERS
 
 
 
12.2.2
GLUCOSE MONITORING
 
 
 
 
 
12.2.2.1
BLOOD GLUCOSE STRIPS
 
 
 
 
12.2.2.2
GLUCOSE MONITORS
 
 
 
 
12.2.2.3
URINE GLUCOSE STRIPS
 
 
 
12.2.3
BLOOD GAS ELECTROLYTE ANALYSIS
 
 
 
 
 
12.2.3.1
REAGENTS, CLIPS, AND CARTRIDGES
 
 
 
 
12.2.3.2
BLOOD GAS & ELECTROLYTE ANALYZERS
 
 
12.3
IMMUNODIAGNOSTICS
 
 
 
 
 
12.3.1
LATERAL FLOW ASSAYS
 
 
 
 
 
12.3.1.1
RAPID TESTS
 
 
 
 
12.3.1.2
STRIP READERS (LATERAL FLOW READERS)
 
 
 
12.3.2
ELISA TESTS
 
 
 
 
12.3.3
ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
 
 
 
 
12.3.4
IMMUNOASSAY ANALYZERS
 
 
 
 
12.3.5
OTHER IMMUNODIAGNOSTIC PRODUCTS
 
 
 
12.4
HEMATOLOGY
 
 
 
 
 
12.4.1
CARTRIDGES
 
 
 
 
12.4.2
ANALYZERS
 
 
 
12.5
URINALYSIS
 
 
 
 
 
12.5.1
CLIPS & CARTRIDGES/PANELS
 
 
 
 
12.5.2
URINE ANALYZERS
 
 
 
 
12.5.3
URINE TEST STRIPS
 
 
 
12.12
MOLECULAR DIAGNOSTICS
 
 
 
 
 
12.6.1
POLYMERASE CHAIN REACTION TESTS
 
 
 
 
12.6.2
MICROARRAYS
 
 
 
 
12.6.3
OTHER MOLECULAR DIAGNOSTIC PRODUCTS
 
 
 
12.10
OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES
 
 
 
13
EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
 
 
 
 
 
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
13.2
DIAGNOSTIC LABORATORIES
 
 
 
 
13.3
VETERINARY HOSPITALS & CLINICS
 
 
 
 
13.4
RESEARCH INSTITUTES & UNIVERSITIES
 
 
 
 
13.5
HOME-CARE SETTINGS
 
 
 
 
NOTE: OTHER END USERS SEGMENT INCLUDES EMERGENCY MEDICAL SERVICE PROVIDERS, ACUTE CARE CENTERS, AND MEDICAL AND ACADEMIC INSTITUTES AMONG OTHERS.
 
 
 
 
14
EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
 
 
 
 
 
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY COUNTRIES
 
 
 
 
 
14.1
INTRODUCTION
 
 
 
 
14.1
EUROPE
 
 
 
 
 
14.2.1
EUROPE VOLUME ANALYSIS – 2024 – 2031 (THOUSAND UNITS)
 
 
 
 
14.2.2
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
14.2.3
GERMANY
 
 
 
 
14.2.4
UK
 
 
 
 
14.2.5
FRANCE
 
 
 
 
14.2.6
ITALY
 
 
 
 
14.2.7
SPAIN
 
 
 
 
14.2.8
BENELUX
 
 
 
 
14.2.9
NETHERLANDS
 
 
 
 
14.2.10
DENMARK
 
 
 
 
14.2.11
BELGIUM
 
 
 
 
14.2.12
REST OF EUROPE
 
 
 
NOTE: REST OF EUROPE INCLUDES RUSSIA, PORTUGAL, POLAND, FINLAND, , AUSTRIA, ICELAND, IRELAND, NORWAY, AND LUXEMBOURG
 
 
 
 
15
COMPETITIVE LANDSCAPE
 
 
 
 
 
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
 
 
 
 
 
 
15.1
OVERVIEW
 
 
 
 
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
15.3
EUROPE REVENUE SHARE ANALYSIS OF KEY PLAYERS (2022-2025)
 
 
 
 
15.4
EUROPE MARKET SHARE ANALYSIS,
 
 
 
 
 
15.5
BRAND COMPARATIVE ANALYSIS
 
 
 
 
15.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
15.6.1
STARS
 
 
 
 
15.6.2
EMERGING LEADERS
 
 
 
 
15.6.3
PERVASIVE PLAYERS
 
 
 
 
15.6.4
PARTICIPANTS
 
 
 
 
15.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
15.6.5.1
COMPANY FOOTPRINT
 
 
 
 
15.6.5.2
COUNTRY FOOTPRINT
 
 
 
 
15.6.5.3
PRODUCT FOOTPRINT
 
 
 
 
15.6.5.4
APPLICATION FOOTPRINT
 
 
15.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
15.7.1
PROGRESSIVE COMPANIES
 
 
 
 
15.7.2
RESPONSIVE COMPANIES
 
 
 
 
15.7.3
DYNAMIC COMPANIES
 
 
 
 
15.7.4
STARTING BLOCKS
 
 
 
 
15.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
15.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
15.7.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
15.8
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
15.9
COMPETITIVE SCENARIO
 
 
 
 
 
15.9.1
PRODUCT LAUNCHES
 
 
 
 
15.9.2
DEALS
 
 
 
 
15.9.3
EXPANSIONS
 
 
 
 
15.9.4
OTHER DEVELOPMENTS
 
 
16
COMPANY PROFILES
 
 
 
 
 
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET LANDSCAPE
 
 
 
 
 
 
16.1.1
IDEXX LABORATORIES, INC.
 
 
 
 
16.1.2
ZOETIS INC.
 
 
 
 
16.1.3
HESKA CORPORATION
 
 
 
 
16.1.4
THERMO FISHER SCIENTIFIC INC
 
 
 
 
16.1.5
BIOMÉRIEUX SA
 
 
 
 
16.1.6
VIRBAC
 
 
 
 
16.1.7
NEOGEN CORPORATION
 
 
 
 
16.1.8
FUJIFILM HOLDINGS CORPORATION
 
 
 
 
16.1.9
INDICAL BIOSCIENCE GMBH
 
 
 
 
16.1.10
IDVET
 
 
 
 
16.1.11
RANDOX LABORATORIES, LTD.
 
 
 
 
16.1.12
SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
 
 
 
 
16.1.13
BIONOTE, INC
 
 
 
16.2
OTHER PLAYERS
 
 
 
 
 
16.2.1
SKYLA CORPORATION
 
 
 
 
16.2.2
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
 
 
 
 
16.2.3
URIT MEDICAL ELECTRONIC CO., LTD.
 
 
 
 
16.2.4
EUROLYSER DIAGNOSTICA GMBH
 
 
 
 
16.2.5
NOVA BIOMEDICAL
 
 
 
 
16.2.6
FASSISI GMBH
 
 
 
 
16.2.7
SWISSAVANS AG
 
 
 
 
16.2.8
ALVEDIA
 
 
 
 
16.2.9
MEGACOR VETERINARY DIAGNOSTICS
 
 
 
 
16.2.10
BIOPANDA REAGENTS LTD
 
 
 
 
16.2.11
ANIPOC LTD
 
 
 
 
16.2.12
RING BIOTECHNOLOGY CO LTD.
 
 
17
RESEARCH METHODOLOGY
 
 
 
 
 
17.1
RESEARCH DATA
 
 
 
 
 
17.1.1
SECONDARY DATA
 
 
 
 
 
17.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
17.1.2
PRIMARY DATA
 
 
 
 
 
17.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
17.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
17.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
17.1.2.4
KEY INDUSTRY INSIGHTS
 
 
17.2
MARKET SIZE ESTIMATION
 
 
 
 
 
17.2.1
BOTTOM-UP APPROACH
 
 
 
 
17.2.2
TOP-DOWN APPROACH
 
 
 
 
17.2.3
BASE NUMBER CALCULATION
 
 
 
17.3
MARKET FORECAST APPROACH
 
 
 
 
 
17.3.1
SUPPLY SIDE
 
 
 
 
17.3.2
DEMAND SIDE
 
 
 
17.4
DATA TRIANGULATION
 
 
 
 
17.5
FACTOR ANALYSIS
 
 
 
 
17.6
RESEARCH ASSUMPTIONS
 
 
 
 
17.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
18
APPENDIX
 
 
 
 
 
18.1
DISCUSSION GUIDE
 
 
 
 
18.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
18.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
18.3.1
PRODUCT ANALYSIS
 
 
 
 
18.3.2
COMPANY INFORMATION
 
 
 
 
18.3.4
COUNTRY LEVEL MARKET SHARE ANALYSIS
 
 
 
 
18.3.5
COUNTRY LEVEL VOLUME ANALYSIS
 
 
 
 
18.3.6
BY PRODUCT MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
 
 
 
 
18.3.7
ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
 
 
 
18.4
RELATED REPORTS
 
 
 
 
18.5
AUTHOR DETAILS
 
 
 
 
*CONTENTS IN THE TOC/ MARKET SEGMENTS ARE TENTATIVE AND MIGHT CHANGE AS THE RESEARCH PROCEEDS.
 
 
 
 
 
*LIST OF COMPANIES IS NOT EXHAUSTIVE AND MIGHT CHANGE DURING COURSE OF STUDY.
 
 
 
 

Methodology

This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

Secondary Research

This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the europe companion animal diagnostics market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the europe companion animal diagnostics market. Primary sources from the demand side included veterinary hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size for europe companion animal diagnostics market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for europe companion animal diagnostics market was calculated using data from three distinct sources, as will be discussed below:

Europe Companion Animal Diagnostics Market

Data Triangulation

The entire market was split up into five segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.

Approach to derive the market size and estimate market growth.

Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of europe companion animal diagnostics. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

Market Definition

Europe companion animal diagnostics are tools that utilize plasma, serum, blood, urine, feces, and tissue samples for the diagnosis of animal diseases and disorders. Europe companion animal diagnostics includes various test kits, tools, and instruments such as clinical chemistry analyzers, hematology analyzers, glucose monitoring systems, urine analyzers, blood gas-electrolyte analyzers, and ELISA test kits.

Stakeholders

  • Companion animal diagnostic manufacturers
  • Companion animal diagnostic distributors & suppliers
  • Companion animal R&D companies
  • Veterinary reference laboratories
  • Veterinary hospitals & clinics
  • Veterinary universities & research institutes
  • Government associations 
  • Market research & consulting firms
  • Venture capitalists & investors
  • Distributors, channel partners, and third-party suppliers

Report Objectives

  • To define, describe, and forecast the europe companion animal diagnostics market based on product, technology, animal type, application, end user and region.
  • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall europe companion animal diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the europe companion animal diagnostics market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC Countries
  • To profile the key players and comprehensively analyze their market shares and core competencies in the europe companion animal diagnostics market
  • To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the europe companion animal diagnostics market
  • To benchmark players within the europe companion animal diagnostics market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Europe Companion Animal Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Europe Companion Animal Diagnostics Market

DMCA.com Protection Status